Vantage Lumbar Decompression Kit
SurGenTec, LLC · Decision date Oct 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-14 for the Vantage Lumbar Decompression Kit, submitted by SurGenTec, LLC of Boca Raton, Florida, under 510(k) number K263208. The application was received on 09/14/2026 and reviewed by FDA's Orthopedic panel without third-party review. SESE in the 510(k) pathway denotes clearance to market, not premarket approval.
The device is listed under the classification name Arthroscope, regulation number 888.1100, with primary product code HRX and subsequent product code HAE; the regulation medical specialty is Orthopedic. The record does not identify a predicate device, describe the kit's components, or state indications for use. The summary document is referenced but its contents are not included here, so the basis for the equivalence determination and any clinical data remain unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263208
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- SurGenTec, LLC
- Product code
- HRX
- Decision code
- SESE
- Decision date
- Oct 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Arthroscope.
- Applicant
- SurGenTec, LLC
- Product code
- HRX
- FDA device class
- 2
FDA decision timeline
K263208 received
Application receipt date recorded by FDA.
K263208 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Nexus CMF, LLC | 510(k) clearance | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
SurGenTec, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Boca Raton, FL
Sources and methodology
- Original FDA record: K263208
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records